|
|
||||||||
Stem Cells, Vol 12, 394-401, Copyright © 1994 by AlphaMed Press
REVIEWS |
A Biondi and A Rambaldi
Clinica Pediatrica Universita di Milano, Monza, Italy.
Evaluation of minimal residual disease (MRD) in different forms of acute leukemias is an expanding field of experimental hematology. Several strategies and techniques, including cytomorphology, immunophenotype and karyotype, have been applied to evaluate MRD, but molecular biology has provided more sensitive and accurate tools to detect the neoplastic clones. This concise review summarizes some of the technical aspects and pitfalls associated with different molecular approaches such as the analysis of clonospecific DNA sequences in lymphoid malignancies and the demonstration of chimeric genomic products generated by chromosomal translocations. The feasibility, specificity and clinical relevance of all these studies will be briefly discussed.
This article has been cited by other articles:
![]() |
A. Tefferi Genomics basics: DNA structure, gene expression, cloning, genetic mapping, and molecular tests. Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2006; 10(4): 282 - 290. [Abstract] [PDF] |
||||
![]() |
A. Rambaldi, G. Borleri, G. Dotti, P. Bellavita, R. Amaru, A. Biondi, and T. Barbui Innovative Two-Step Negative Selection of Granulocyte Colony-Stimulating Factor-Mobilized Circulating Progenitor Cells: Adequacy for Autologous and Allogeneic Transplantation Blood, March 15, 1998; 91(6): 2189 - 2196. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
